Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 17 | 7675397 | 5 prime UTR variant | T/C | snv | 0.18 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Neoplasms | 0.100 | 0.933 | 45 | 2002 | 2019 | |||||||
|
0.439 | 0.800 | 17 | 7676154 | frameshift variant | -/C | ins |
|
Neoplasms | 0.100 | 0.923 | 39 | 2002 | 2019 | ||||||||
|
0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv |
|
Neoplasms | 0.100 | 0.923 | 39 | 2002 | 2019 | ||||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Neoplasms | 0.100 | 0.921 | 38 | 2005 | 2019 | |||||||
|
0.439 | 0.800 | 17 | 7676154 | frameshift variant | -/C | ins |
|
Neoplasms | 0.100 | 0.909 | 33 | 2005 | 2019 | ||||||||
|
0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv |
|
Neoplasms | 0.100 | 0.909 | 33 | 2005 | 2019 | ||||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.727 | 22 | 2006 | 2019 | |||||||
|
0.554 | 0.600 | 17 | 7673802 | missense variant | C/A;G;T | snv | 4.0E-06; 1.6E-05 |
|
Neoplasms | 0.100 | 0.923 | 13 | 1993 | 2019 | |||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Neoplasms | 0.100 | 0.833 | 12 | 2006 | 2019 | |||||||
|
0.554 | 0.600 | 17 | 7673802 | missense variant | C/A;G;T | snv | 4.0E-06; 1.6E-05 |
|
Neoplasms | 0.100 | 1.000 | 12 | 2005 | 2019 | |||||||
|
0.605 | 0.600 | 17 | 7675088 | missense variant | C/A;T | snv | 4.0E-06 |
|
Neoplasms | 0.780 | 0.909 | 11 | 2000 | 2019 | |||||||
|
0.627 | 0.400 | 17 | 7673751 | missense variant | C/A;G;T | snv | 1.6E-04 | 1.3E-04 |
|
Neoplasms | 0.100 | 0.900 | 10 | 2014 | 2019 | ||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 1.000 | 7 | 2010 | 2019 | |||||||
|
0.605 | 0.680 | 17 | 7674221 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms | 0.760 | 0.857 | 7 | 1999 | 2019 | |||||||
|
0.627 | 0.400 | 17 | 7673751 | missense variant | C/A;G;T | snv | 1.6E-04 | 1.3E-04 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2010 | 2019 | ||||||
|
0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv |
|
Neoplasms | 0.060 | 0.833 | 6 | 2010 | 2019 | ||||||||
|
0.605 | 0.600 | 17 | 7675088 | missense variant | C/A;T | snv | 4.0E-06 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||||
|
0.605 | 0.600 | 17 | 7675088 | missense variant | C/A;T | snv | 4.0E-06 |
|
Neoplasms | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||||
|
0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 |
|
Mental Disorders | 0.050 | 0.600 | 5 | 2001 | 2019 | |||||||
|
0.592 | 0.640 | 17 | 7674220 | missense variant | C/A;G;T | snv | 1.2E-05 |
|
Neoplasms | 0.710 | 1.000 | 5 | 2014 | 2019 | |||||||
|
0.592 | 0.640 | 17 | 7674220 | missense variant | C/A;G;T | snv | 1.2E-05 |
|
Neoplasms | 0.050 | 0.800 | 5 | 1993 | 2019 | |||||||
|
0.630 | 0.320 | 17 | 7670699 | missense variant | C/A;G;T | snv | 1.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases | 0.050 | 1.000 | 5 | 2011 | 2019 | |||||||
|
0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.050 | 1.000 | 5 | 2004 | 2019 | |||||||
|
0.662 | 0.360 | 17 | 7668434 | 3 prime UTR variant | T/G | snv | 8.3E-03 |
|
Neoplasms | 0.700 | 1.000 | 5 | 2011 | 2019 |